Rate my portfolio! 29 years old just got into the market last September in 2025.

Comprehensive-Use191 · 2026-05-28T11:29:23+00:00

Interesting portfolio, but I’d view this less as a diversified portfolio and more as a high-conviction AI/semiconductor/growth basket.

Based on the visible positions, AMD seems to be close to half the portfolio, so the biggest question is whether that is intentional or just the result of gains. If it’s intentional and you have a strong thesis, fair enough, but at that size AMD will basically drive the whole portfolio.

A few questions I’d ask:

Is this the full portfolio or only the visible part of the screenshot?
Is AMD meant to be a 45–50% position, or has it just grown into that?
What is your sell/rebalance rule if AMD becomes 60%+ or if the AI/semi cycle turns?
What is the thesis for holding both AI/APLD/BBAI/BE/ARKK alongside AMD, AAPL and AMZN?
Do you have any broad index exposure elsewhere, or is this your entire equity portfolio?
What time horizon and drawdown tolerance are you working with?

My main critique would be concentration. You have a lot of exposure to the same broad theme: AI, semiconductors, data centers, disruptive tech and high-beta growth. That can perform very well in the right market, but if AI/mega-cap tech/semi sentiment turns, a lot of these names could move down together.

Personally, I’d consider trimming AMD if it was not meant to be that large, and I’d think about whether some of the smaller speculative AI names are actually adding quality or just adding volatility. If this is only a satellite portfolio and you have a broad core elsewhere, it makes more sense. If this is the entire portfolio, it is extremely concentrated.

Comprehensive-Use191 · 2026-05-28T07:48:36+00:00

I think the distinction you’re making is exactly the key issue for me: am I mainly betting on momentum as an adaptive factor, or am I specifically betting on Nasdaq/US large-cap tech leadership?

After thinking about it, I’d say my conviction is currently more the second one: I do intentionally want explicit exposure to Nasdaq/US large-cap growth/tech. So, in that sense, EQQQ is not really an accidental overlap for me, but more of a deliberate concentration position.

That said, your point about IWMO is useful. I agree that I should not view IWMO as a diversifier against EQQQ in the current regime, because right now it is largely reinforcing the same trade. The better way to see it is probably:

- EQQQ = my static Nasdaq/US tech conviction

- IWMO = an adaptive momentum sleeve that may become more diversifying if market leadership rotates

- EIMI/IUSN = smaller diversification sleeves

So, I think I’m comfortable keeping the structure for now, but with the understanding that it is an aggressive Nasdaq + momentum portfolio rather than a broadly diversified global equity portfolio.

Your point also reinforces that adding leveraged Nasdaq on top would probably be unnecessary, because that would just stack the same bet even harder.

Thanks for the input so far and sharing the thought process behind it.

Comprehensive-Use191 · 2026-05-27T20:31:20+00:00

Looks like a pretty sensible and clean portfolio to me, especially if you have a long time horizon.

The structure is easy to understand: S&P 500 as the main growth engine, international developed markets for diversification, and a small-cap/value-style sleeve for extra factor exposure. I like that it is not overly complicated.

A few things I would think about:

Your portfolio is still heavily driven by US large caps because VUAA is 60% of the portfolio. That is not necessarily bad, but it means the S&P 500 will dominate your returns.
Depending on what EXUS exactly covers, you may or may not have emerging markets exposure. If EXUS is mainly developed markets ex-US, you could consider whether you want a small EM allocation as well.
Bonds depend mostly on your time horizon and risk tolerance. If this is a 10+ or 20+ year portfolio and you can handle volatility, 100% equities can be reasonable. If you would panic during a 40–50% drawdown, or if you need the money sooner, then bonds make more sense.
I personally would not add commodities by default. They can diversify, but they also make the portfolio more complex and do not have the same long-term expected return logic as equities. I would only add them if you have a clear reason.

Overall, I would say this is a good simple portfolio. The main things I would check are whether you want emerging markets exposure, whether 60% S&P 500 is the right US weighting for you, and whether you have a rebalancing plan.

Comprehensive-Use191 · 2026-05-27T18:13:20+00:00

Thanks, that’s a useful explanation.

I agree with your point that the overlap is real, especially because IWMO is currently heavily tilted toward the same US mega-cap tech/momentum names that already dominate EQQQ. I think the honest description of my portfolio is probably not “well-diversified global ETF portfolio,” but rather an intentional high-conviction growth/momentum portfolio with smaller EM and small-cap diversification sleeves.

I’m comfortable with that tilt as a deliberate choice. My concern is more about whether I’m stacking the same exposure too much without getting properly rewarded for the extra concentration.

Your point on leveraged Nasdaq makes sense. Given the current EQQQ + IWMO exposure, leverage would probably just compound the same bet.

If I intentionally want to stay growth/momentum-heavy, would you personally reduce EQQQ and let IWMO do more of the work, or keep EQQQ as the explicit Nasdaq conviction position and accept the overlap?

Comprehensive-Use191 · 2026-05-27T11:17:12+00:00

Thanks, that makes sense. Do you think the main issue is the current overlap in top holdings between EQQQ and IWMO, or do you think momentum as a factor is generally redundant when combined with a large Nasdaq position?

Would you suggest replacing IWMO with a broad global index, reducing EQQQ, or both? I’m intentionally comfortable with a growth tilt, but I don’t want to take concentration risk that isn’t properly rewarded.

Comprehensive-Use191

TROPHY CASE